glp-1 agonist cardiovascular outcomes in major trials with receptor agonists Cardiovascular disease continuum-GLP-1 action. Adapted
Description
10.1186/s12902-024-01775-2 69 SommE.MontandonS
Still, high-doses of tirzepatide stimulates insulin secretion and lowers glycemia in mice with selective deletion of either the Gipr or Glp1r , supporting in vivo activity at both receptors 44,45
doi: 10.1177/87551225221092681 82 JastreboffAMAronneLJAhmadNNWhartonSConneryLAlvesBet al
PMID: 37821008
